Simplex Trading, LLC Rubius Therapeutics, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$0.02 - $0.34 $77 - $1,311	3,856 New	3,856 $0
Q2 2022 Aug 03, 2022	SELL	$0.79 - $5.98 $83,686 - $633,473	-105,932 Reduced 99.73%	288 $0
Q1 2022 May 02, 2022	BUY	$4.25 - $10.4 $440,270 - $1.08 Million	103,593 Added 3943.4%	106,220 $585,000
Q4 2021 Feb 23, 2022	BUY	$9.68 - $17.74 $3,068 - $5,623	317 Added 13.72%	2,627 $25,000
Q2 2021 Aug 12, 2021	SELL	$22.26 - $28.43 $156,599 - $200,005	-7,035 Reduced 75.28%	2,310 $56,000
Q1 2021 Apr 26, 2021	BUY	$8.02 - $32.01 $74,946 - $299,133	9,345 New	9,345 $247,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.